The pathogenetic features of cerebral cavernous malformations: A comprehensive review with therapeutic implications

Neurosurgical Focus

Volumn 29, Issue 3, 2010, Pages 1-6

  Krisht, Khaled M ^a   Whitehead, Kevin J ^a   Niazi, Toba ^a   Couldwell, William T ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

CCM gene; Cerebral cavernous malformation; Signal transduction pathway; Simvastatin

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; CCM2 PROTEIN, HUMAN; KRIT1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; ONCOPROTEIN; PDCD10 PROTEIN, HUMAN; SIMVASTATIN;

ANIMAL; BRAIN HEMANGIOMA; DISEASE MODEL; GENETICS; HUMAN; MOUSE; PATHOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; MEMBRANE PROTEINS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; SIMVASTATIN;

EID: 77956212617     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2010.6.FOCUS10135     Document Type: Article

References (19)

1. Bayless KJ, Davis GE, Microtubule depolymerization rapidly collapses capillary tube networks in vitro and angiogenic vessels in vivo through the small GTPase Rho. J Biol Chem 279:11686-11695, 2004
2. Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, et al, Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 76:42-51, 2005
3. Borikova AL, Dibble CF, Sciaky N, Welch CM, Abell AN, Bencharit S, et al, Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J Biol Chem 285:11760-11764, 2010
4. Chan AC, Li DY, Berg MJ, Whitehead KJ, Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype. FEBS J 277:1076-1083, 2010
5. Faurobert E, Albiges-Rizo C, Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction. FEBS J 277:1084-1096, 2010
6. Leblanc GG, Golanov E, Awad IA, Young WL, Biology of vascular malformations of the brain. Stroke 40:e694-e702, 2009
7. Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, et al, Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73:1459-1464, 2003
8. Moriarity JL, Wetzel M, Clatterbuck RE, Javedan S, Sheppard JM, Hoenig-Rigamonti K, et al, The natural history of cavernous malformations: a prospective study of 68 patients. Neurosurgery 44:1166-1173, 1999
9. Otten P, Pizzolato GP, Rilliet B, Berney J, [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies.] Neurochirurgie 35:82-83, 128-131, 1989 (Fr)
10. Petit N, Blécon A, Denier C, Tournier-Lasserve E, Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development. Gene Expr Patterns 6:495-503, 2006
11. Plummer NW, Squire TL, Srinivasan S, Huang E, Zawistowski JS, Matsunami H, et al, Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations. Mamm Genome 17:119-128, 2006
12. Reich P, Winkler J, Straube A, Steiger HJ, Peraud A, Molecular genetic investigations in the CCM1 gene in sporadic cerebral cavernomas. Neurology 60:1135-1138, 2003
13. Revencu N, Vikkula M, Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet 43:716-721, 2006
14. Riant F, Bergametti F, Ayrignac X, Boulday G, Tournier-Lasserve E, Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J 277:1070-1075, 2010
15. Robinson JR, Awad IA, Little JR, Natural history of the cavernous angioma. J Neurosurg 75:709-714, 1991
16. Seker A, Pricola KL, Guclu B, Ozturk AK, Louvi A, Gunel M, CCM2 expression parallels that of CCM1. Stroke 37:518-523, 2006
17. Stockton RA, Shenkar R, Awad IA, Ginsberg MH, Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 207:881-896, 2010
18. Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, et al, The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 15:177-184, 2009 (Erratum in Nat Med 15:462, 2009)
19. Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, Johnson GL, et al, CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet 14:2521-2531, 2005